Alliance Global Partners analyst Aaron Grey initiated coverage of Waldencast (WALD) with a Buy rating and $5 price target The company aims to become a multi-brand beauty and wellness company, which today consists of its Milk Makeup brand and Obagi, the analyst tells investors in a research note. The firm says both brands offer “robust” growth and margins, which should continue in 2025. It views Waldencast as an “appealing investment proposition with potential for multiple re-rating by the end of year.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WALD:
- Waldencast’s Obagi Medical announces launch of Retinol + PHA cream
- Elf Beauty, Helen of Troy exposed to China tariffs, says Canaccord
- Waldencast’s Earnings Call Highlights Growth and Innovation
- Waldencast price target lowered to $3.40 from $4.30 at TD Cowen
- Waldencast Acquisition: Hold Rating Amid Near-Term Challenges and Long-Term Potential